EP3082758A2 - Human sebum mimetics derived from botanical sources and methods for making the same - Google Patents
Human sebum mimetics derived from botanical sources and methods for making the sameInfo
- Publication number
- EP3082758A2 EP3082758A2 EP14873000.5A EP14873000A EP3082758A2 EP 3082758 A2 EP3082758 A2 EP 3082758A2 EP 14873000 A EP14873000 A EP 14873000A EP 3082758 A2 EP3082758 A2 EP 3082758A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- human sebum
- human
- mimetic composition
- sebum mimetic
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present invention generally relates to personal care compositions and methods for manufacturing them, and more particularly relates to human sebum mimetics derived from botanical sources and methods for making them.
- Sebum Human sebum is secreted by the sebaceous glands that are found over substantially the entire skin surface (except the palms of the hands and soles of the feet), but are found predominately on the scalp, face, chest, and back. Sebum is involved in development of the epidermal structure and maintenance of the epidermal permeability barrier, carrying anti-oxidants to the skin surface, protecting the skin from microbial colonization, generating body odor, and providing UV protection.
- sebum When secreted, human sebum is a complex mixture of triglycerides, wax esters, cholesterol, cholesterol esters, and squalene. As the sebum is secreted, it consists primarily of triglycerides and wax esters, which are broken down by microbes into diglycerides, monoglycerides, and the constituent free fatty acids.
- the fatty acid chain lengths of human sebum vary considerably, but have predominantly 16 and 18 carbons, such as in the case of stearic acid (18 carbons with no double bond (hereinafter denoted 18:0)), oleic acid (18: 1 with one double bond on the ninth carbon (hereinafter denoted 18: 1 ⁇ 9)), linoleic acid (18:2 ⁇ 9 ⁇ 12), palmitic acid (16:0), and sapienic acid (16: 1 ⁇ 6).
- Loss of sebum over time can be due to a variety of environmental factors such as bathing, weather conditions, chemical products, poor nutrition, and genetic factors. For example, a natural lack of sebum is observed on the scalp of African- Americans.
- a loss of sebum can result in itching, dandruff, wrinkles, diaper rash and the like on the skin.
- the hair may become brittle and dry without a sufficient amount of sebum to moisturize it.
- many of these products contain synthetic components or components that are derived from animals and do not mimic the structure and formulation of human sebum.
- the products are not absorbed by the skin as readily as human sebum.
- the products are often made from unstable ingredients that exhibit a short shelf life.
- a human sebum mimetic may comprise a wax ester derived from interesterification of a refined botanical triglyceride oil comprising palmitoleic acid and jojoba oil (optionally refined), a phytosterol, and phytosqualene.
- a method for producing a human sebum mimetic may comprise mixing refined macadamia oil and refined jojoba oil, interesterifying the macadamia oil and the jojoba oil, adding a phytosterol before or after the interesterification, and adding phytosqualene after interesterifying.
- a human sebum mimetic may comprise a wax ester having a fatty acid comprising 16 carbons and one double bond (said wax ester being derived from a plant source), a phytosterol, and phytosqualene.
- the human sebum mimetic may comprise a wax ester having a fatty acid comprising 16 carbons and one double bond (said wax ester being derived from a plant source), a phytosterol, phytosqualene, and a phytosteryl acylate.
- a human sebum mimetic may comprise a wax ester derived from interesterification of a refined botanical oil comprising hexadec-9-enoic acid and refined jojoba oil, a phytosterol, phytosqualene, and phytosteryl macadamiate.
- a human sebum mimetic may comprise a wax ester derived from interesterification of a refined botanical oil comprising palmitoleic acid and refined jojoba oil, a phytosterol, phytosqualene, phytosteryl macadamiate, and a constituent lipid of human stratum corneum.
- compositions that mimic human sebum.
- the approximate composition of human sebum includes by weight percent (wt.%) (from Pierre Agache, "Sebaceous Physiology,"
- the human sebum mimetics contemplated herein are plant based; that is, the components of the mimetics are derived either physically or chemically from plant sources.
- the mimetics are plant-derived analogs of human sebum in that they are derived from phytosqualene, phytosterols, a botanical oil (optionally refined) such as macadamia oil (which is the source of the mimetic's triglycerides), and jojoba oil (which is the source of the mimetic's wax ester fraction).
- a botanical oil such as macadamia oil (which is the source of the mimetic's triglycerides), and jojoba oil (which is the source of the mimetic's wax ester fraction).
- refined oil means crude oil that has had undesirable compounds such as free fatty acids, carbohydrates, metals, proteins, and/or the like removed.
- the human sebum mimetic is derived from phytosqualene in an amount of about 5 to about 20 wt.% of the entire mimetic, refined jojoba oil in an amount of about 20 to about 35 wt.% of the entire mimetic, refined macadamia oil in an amount of about 45 to about 65 wt.% of the entire mimetic, and phytosterols in an amount of about 0.5 to about 10 wt.% of the entire mimetic.
- the human sebum mimetic is derived from phytosqualene in an amount of about 11 to about 15 wt.% of the entire mimetic, refined jojoba oil in an amount of about 29 to about 33 wt.% of the entire mimetic, refined macadamia oil in an amount of about 51 to about 55 wt.% of the entire mimetic, and phytosterols in an amount of about 1 to about 5 wt.% of the entire mimetic.
- the human sebum mimetic is substantially derived from the following composition in weight percent:
- the human sebum mimetics contemplated herein also comprise high levels of palmitic acid and oleic acid, as macadamia oil itself comprises about 8.8 wt % palmitic acid and about 58 wt.% oleic acid.
- the human sebum mimetic comprises about 1 to about 10 wt.% palmitic acid, in a preferred embodiment about 3 to about 7 wt.% palmitic acid, and in a more preferred embodiment about 4.8 wt.% palmitic acid.
- the human sebum comprises about 25 to about 35 wt.% oleic acid, in a preferred embodiment about 30 to about 34 wt.% oleic acid, and in a more preferred embodiment about 31.6 wt.% oleic acid.
- palmitoleic acid (16: 1 ⁇ 9) (also referred to as palmitoleic acid), an analog of sapienic acid, is a substitute for the sapienic acid. While palmitoleic acid is fairly rare in the plant kingdom, macadamia oil has the highest palmitoleic acid content of the currently- available commercial oils, with about 16-22% palmitoleic acid. Accordingly, the inventors have found that by interesterifying the refined macadamia oil and the refined jojoba oil of the human sebum mimetic, a wax ester comprising palmitoleic acid results.
- the genera of these species include Thunbergia, Doxantha, Alophia, Roureopsis, Telopea, and Asclepias .
- the human sebum mimetic comprises palmitoleic acid in an amount of about 5 to about 15 wt.% of the entire mimetic composition. In a preferred embodiment, the human sebum mimetic comprises palmitoleic acid in an amount of about 8 to about 12 wt.% of the entire mimetic composition, and, in a more preferred embodiment, the human sebum mimetic comprises palmitoleic acid in an amount of about 9.7 wt.% of the entire mimetic composition. In a most preferred embodiment, the human sebum mimetic comprises the following fatty acids and fatty alcohols in weight percent:
- the human sebum mimetic may comprise an acylate.
- the acylate may comprise an acylated alcohol wherein the alcohol originates from any suitable source.
- the acylated alcohol may be a stearyl ester.
- the stearyl ester may be a phytosteryl acylate.
- the phytosteryl acylate may be an ester of phytosterol and the fatty acids derived from any suitable plant source.
- the phytosteryl acylate may comprise phytosteryl macadamiate derived from macadamia oil.
- the human sebum mimetic may comprise the compositional lipid profile of the sebum of any selected profile, such as an exemplary 22 year old human female.
- the human sebum mimetic may be derived from interesterifying refined jojoba oil in an amount of about 24.9 wt.% of the entire mimetic and a refined botanical oil comprising a triglyceride, wherein the refined botanical oil comprises palmitoleic acid in an amount of about 61.9 wt.% of the entire mimetic.
- the refined botanical oil comprising palmitoleic acid may comprise refined macadamia oil.
- the mimetic may further comprise phytosqualene in an amount of about 12.6 wt.% of the entire mimetic, phytosterols in an amount of about 0.4 wt.% of the entire mimetic, phytosteryl macadamiate in an amount of about 0.1 wt.% of the entire mimetic, and/or tocopherols in an amount of about 0.1 wt.% of the entire mimetic (about 1000 parts per million).
- the human sebum mimetic may further comprise an effective amount of any constituent lipid found in a stratum corneum layer of an epidermis.
- the human sebum mimetic may comprise a derivative and/or precursor of the constituent lipid.
- the constituent lipid may be present in the human sebum mimetic in an effective amount to organize the intercellular lamellar lipid structure of the stratum corneum to at least partially promote and/or maintain the water permeability barrier function of the skin.
- the constituent lipid may comprise fatty acids such as long chain saturated fatty acid having chain lengths of C16 to C30 and/or unsaturated fatty acids such as linoleate.
- the constituent lipid may comprise a ceramide and/or a sphingolipid.
- Ceramides may comprise a structurally heterogeneous family of sphingolipid base derivatives with amide linkages to a variety of long- chain fatty acids.
- the ceramide may comprise any one or more ceramides found in human stratum corneum, such as acylceramides.
- the mimetic may comprise the ceramide in an amount up to about 27 wt.% of the entire mimetic.
- Sphingolipids may comprise any one or more of the structurally heterogeneous family of lipids.
- the sphingolipids may have eighteen carbon amino-alcohol backbones that may be called sphingoid bases.
- the mimetic may comprise the sphingolipid in an amount up to about 27 wt.% of the entire mimetic.
- the constituent lipid may comprise a phospholipid.
- the phospholipid may comprise any lipid containing phosphoric acid as a monoester or a diester.
- the phospholipid may comprise any of the amphipathic phospholipids that are part of the main components of cell membranes.
- the phospholipid may comprise one or more of phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, and/or phosphatidylserine.
- the phospholipid may comprise derivatives of phospholipids such as sphingomyelin.
- the phospholipid may be at least partially purified from a source.
- the source may comprise any suitable source of phospholipids such as soybean, rapeseed, and/or sunflower oils.
- the phospholipid may be provided in an unpurified source such as in lecithin.
- the phospholipid may be present in the human sebum mimetic in an effective amount to provide one or more derivatives for biosynthesis of the stratum corneum, such as the biosynthesis of Ceramide I.
- the phospholipid may be present in the human sebum mimetic in an effective amount to organize an extracellular mono- or oligolamellar layer on the skin to at least partially promote and/or maintain the barrier function of the skin.
- the phospholipid may remain on the skin after washing.
- the phospholipid may at least partially improve moisture in the skin, may improve inflammation of the skin such as from atopic dermatitis and/or acne vulgaris, may protect the skin from degreasing, and/or may promote smoothness of the skin.
- the phospholipid may comprise a transdermal delivery system for transporting active agents such as fat- soluble vitamins, plant oils, and/or other active ingredients to the stratum corneum layer of the skin.
- the delivery system may comprise a liposome with an inner aqueous core enclosed in one or more phospholipid layers.
- the delivery system may further comprise non-phospholipid components such as fat-soluble active agents including 1% tocopherol.
- the delivery system may comprise any shape or size to facilitate fixation and/or penetration of the stratum corneum to deliver the active agent to the skin.
- any human sebum mimetic may further comprise an effective amount of trace constituents of the stratum corneum layer of an epidermis.
- the trace constituent may comprise cholesterol such as cholesterol sulfate.
- the cholesterol sulfate may comprise a portion of a human sebum mimetic in an amount similar to the amount of cholesterol sulfate found in a stratum corneum, such as up to about 2 to about 5 wt.% of the entire mimetic.
- the trace constituent may be a mineral such as calcium
- the mimetic may comprise the trace constituent in an amount up to about 12 wt.% of the entire mimetic.
- the human sebum mimetics contemplated herein comprise additional functional additives, that is, an ingredient added to perform a particular function.
- the human sebum mimetics may comprise tocopherols.
- the human sebum mimetic comprises about 100 to about 2000 parts per million (ppm) of 70% tocopherols, preferably about 1430 ppm.
- the human sebum mimetics may also comprise fragrances, dyes, pigments, preservatives, antioxidants, moisturizers, and the like.
- the human sebum mimetics may comprise emollients or thickeners, such as, FLORAESTERS 20 (FE-20) available from International Flora Technologies, Ltd. of Chandler, Arizona. FLORAESTERS 20 may be used to increase the viscosity and/or the bulk melting/dropping point of the mimetic, to more closely replicate the wax ester profile of human sebum, etc.
- the human sebum mimetics may be used as a component in a wide range of personal care products, such as a hair care lotions, shampoos, hair conditioners, hair gels, hair oils, hair colors, hair relaxers, hand lotions, facial lotions, eye creams, facial soaps, body lotions and creams, body scrubs, shaving gels, hair removers, sanitary wipes, and the like.
- personal care products such as a hair care lotions, shampoos, hair conditioners, hair gels, hair oils, hair colors, hair relaxers, hand lotions, facial lotions, eye creams, facial soaps, body lotions and creams, body scrubs, shaving gels, hair removers, sanitary wipes, and the like.
- the human sebum mimetics may facilitate the natural healing and recovery system of the human skin and accelerate cell turn-over and topical blood circulation, thereby decreasing the appearance of wrinkles, dark circles under eyes, and age spots.
- the human sebum mimetics may also reduce irritation on the scalp through natural healing and improve
- the human sebum mimetics contemplated herein are particularly suitable as substitutes for lost human sebum due to their stability. Oil stability is measured according to the American Oil Chemists' Society's Official Method Cd 12b-92 at 110°C. In one embodiment, the human sebum mimetics contemplated herein have an oil stability index greater than about 50 hours at 110°C. In another embodiment, the human sebum mimetics contemplated herein have an oil stability index greater than about 40 hours at 110°C. In this regard, the mimetics are substantially resistant to oxidation and have a shelf life that makes them desirable as, and in, personal care products.
- a method for producing a human sebum mimetic comprises mixing refined macadamia oil and refined jojoba oil, interesterifying the refined macadamia oil and the refined jojoba oil to produce a wax ester comprising a fatty acid having 16 carbons and one double bond, adding a phytosterol, and adding phytosqualene.
- Phytosterol can be added to the refined macadamia oil and the refined jojoba oil before interesterification and/or after interesterification.
- the resulting human sebum mimetic can then be bleached and/or deodorized.
- a mixture of 53.2 grams (g) refined macadamia oil, 30.8 g refined jojoba oil and 2.1 g phytosterol are mixed and heated to 90°C while stirring under vacuum. After about 0.5 hours, 0.84 g sodium methoxide is added to the mixture and the temperature is increased to 130°C and maintained at that temperature for about 2 to about 2.5 hours. The mixture is then cooled to 90°C, and 0.84 g citric acid is added with stirring for 0.5 hours. The mixture is then filtered. 1 g phytosterol and 12.9 g phytosqualene is added to the filtrate, which is mixed until homogeneity is achieved, resulting in the mimetic. 1 wt.% bleaching earth (Clarion 470 bleaching clay available from American
- Colloid Company Arlington Heights, 111.
- Colloid Company Arlington Heights, 111.
- the mimetic may be heated to 95°C and maintained for 15 to 30 minutes with stirring under vacuum. The mixture is filtered. To remove odors and other volatile materials, the mimetic may be heated to 200-220°C under high vacuum while water vapor is injected into it. The temperature is maintained for about 2 hours and then cooled while still under vacuum. In a preferred embodiment, 1430 ppm tocopherol (70%) is added and mixed into the mimetic. Any additional additives also may be added at this time.
- Example 1 is a hair conditioning lotion providing multiple functions including moisturizing, shining, holding, and anti-breaking functions.
- the hair conditioning lotion of Example 1 is manufactured by heating the water to 45°C with stirring and adding the Polyquaternium-37 with medium propeller agitation. The solution is mixed until a clear gel forms. The remaining ingredients in Phase A are added to the gel in the order listed. The ingredients in Phase B are added together at 45°C. The mixture of the Phase B ingredients is then added to the ingredients of Phase A with rapid propeller agitation. The Phase A and B ingredients are heated to 60°C, and the Phase C ingredient is added with medium propeller agitation. All ingredients of Phase D are mixed at 60°C and are added to the Phase ABC mixture with medium propeller agitation. The resulting formula is cooled quickly on an ice-water bath. The fragrance of Phase E is then added.
- Example 2 is another hair conditioning lotion providing multiple functions including moisturizing, shining, holding, and anti-breaking functions.
- the hair conditioning lotion of Example 2 is manufactured using the same method as described above for Example 1.
- human sebum mimetics and methods for producing them have been provided.
- the human sebum mimetics are formed from phytosqualene, phytosterols, refined jojoba oil, and a refined botanical oil, such as macadamia oil, comprising palmitoleic acid.
- human sebum has particularly high levels of palmitic acid (16:0), sapienic acid (16: 1 ⁇ 6), and oleic acid (08: 1 ⁇ 9).
- the human sebum mimetics contemplated herein also comprise high levels of palmitic acid and oleic acid.
- the human sebum mimetics comprise about 1 to about 10 wt.% palmitic acid and about 25 to about 35 wt.% oleic acid.
- sapienic acid is unique among mammals and rarely found in nature. The inventors have found that by interesterifying the refined macadamia oil and the refined jojoba oil of the human sebum mimetics, a wax ester comprising palmitoleic acid, a substitute for sapienic acid, results.
- the human sebum mimetics comprise palmitoleic acid in an amount of about 5 to about 15 wt.% of the entire mimetic composition.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/132,260 US9289373B2 (en) | 2009-10-26 | 2013-12-18 | Human sebum mimetics derived from botanical sources and methods for making the same |
PCT/US2014/070270 WO2015095010A2 (en) | 2013-12-18 | 2014-12-15 | Human sebum mimetics derived from botanical sources and methods for making the same |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3082758A2 true EP3082758A2 (en) | 2016-10-26 |
EP3082758A4 EP3082758A4 (en) | 2017-08-23 |
Family
ID=53403864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14873000.5A Ceased EP3082758A4 (en) | 2013-12-18 | 2014-12-15 | Human sebum mimetics derived from botanical sources and methods for making the same |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3082758A4 (en) |
JP (1) | JP6562921B2 (en) |
CA (1) | CA2932042C (en) |
WO (1) | WO2015095010A2 (en) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2674748B1 (en) * | 1991-04-03 | 1995-01-13 | Oreal | USE OF SPHINGOLIPIDS IN THE PREPARATION OF A COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION PROTECTING THE SKIN AND HAIR FROM THE HARMFUL EFFECTS OF ATMOSPHERIC POLLUTION. |
US20020098207A1 (en) * | 1999-02-08 | 2002-07-25 | Daniel H. Maes | Cholesterol sulfate compositions for enhancement of stratum corneum function |
KR100371491B1 (en) * | 1999-07-27 | 2003-02-07 | 주식회사 두산 | Cream Composition For Skin Care |
IT1317890B1 (en) * | 2000-08-03 | 2003-07-15 | Idi Irccs | PREPARATION TO BE USED AS A LIPID COMPONENT IN COSMETICS. |
IT1317911B1 (en) * | 2000-09-28 | 2003-07-15 | Idi Irccs | COSMETIC FORMULATION. |
FR2831442B1 (en) * | 2001-10-30 | 2005-02-11 | Oreal | COSMETIC COMPOSITION MIMING THE SEBUM, AND USES THEREOF |
EP1534213B1 (en) * | 2002-03-13 | 2013-04-24 | Sköld, Thomas | Water-based delivery systems |
US8765106B2 (en) * | 2009-10-26 | 2014-07-01 | International Flora Technologies, Ltd. | Human sebum mimetics derived from botanical sources and methods for making the same |
US8343468B2 (en) * | 2009-10-26 | 2013-01-01 | International Flora Technologies, Ltd. | Human sebum mimetics derived from botanical sources and methods for making the same |
US9200236B2 (en) * | 2011-11-17 | 2015-12-01 | Heliae Development, Llc | Omega 7 rich compositions and methods of isolating omega 7 fatty acids |
AU2013312920B2 (en) * | 2012-09-05 | 2018-05-24 | International Flora Technologies, Ltd. | Human sebum mimetics derived from botanical sources and methods for making the same |
-
2014
- 2014-12-15 WO PCT/US2014/070270 patent/WO2015095010A2/en active Application Filing
- 2014-12-15 CA CA2932042A patent/CA2932042C/en active Active
- 2014-12-15 EP EP14873000.5A patent/EP3082758A4/en not_active Ceased
- 2014-12-15 JP JP2016535212A patent/JP6562921B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2015095010A2 (en) | 2015-06-25 |
EP3082758A4 (en) | 2017-08-23 |
JP6562921B2 (en) | 2019-08-21 |
CA2932042C (en) | 2020-06-02 |
JP2016540760A (en) | 2016-12-28 |
CA2932042A1 (en) | 2015-06-25 |
WO2015095010A3 (en) | 2015-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8765105B2 (en) | Human sebum mimetics derived from botanical sources and methods for making the same | |
JP2004501069A (en) | Beauty composition | |
AU2012297007A1 (en) | Medicinal skin protection composition with an active ingredient combination which improves the skin barrier | |
US9289373B2 (en) | Human sebum mimetics derived from botanical sources and methods for making the same | |
KR100545836B1 (en) | Cosmetic composition for skin irritation relief containing nanoliposomes of intracellular lipid components | |
KR102558185B1 (en) | Cosmetic composition containing pseudo-ceramide originated from botanical oil | |
KR101325553B1 (en) | Cosmetic Composition for Protecting Skin Comprising Aminolevulinic acid Contained in Liquid Crystal Base | |
CA2884331C (en) | Human sebum mimetics derived from botanical sources and methods for making the same | |
US8765106B2 (en) | Human sebum mimetics derived from botanical sources and methods for making the same | |
JP2001233754A (en) | Emulsion type skin care preparation | |
JP2004505904A (en) | Preparation for sebum used as lipid component in cosmetics | |
CA2932042C (en) | Human sebum mimetics derived from botanical sources and methods for making the same | |
JP3671103B2 (en) | Cosmetics | |
US20150004139A1 (en) | Emollient Compounds Useful for Treating Dry Skin Conditions | |
KR100858626B1 (en) | Cosmetic Composition for Protecting lip Comprising Ceramide and Synthetic Palmitoylpentapeptide as an Active Ingredient | |
JP2000229811A (en) | Skin lotion | |
KR102148454B1 (en) | Hourse fat with improved storage stability | |
EP1693050A1 (en) | Care product for skin and/or hair, and the use thereof | |
RU2170569C1 (en) | Cosmetic cream | |
KR910003106B1 (en) | Cosmetic composition containing liposome and spingolipid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20160617 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20170726 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61Q 19/00 20060101ALI20170720BHEP Ipc: A61Q 5/12 20060101ALI20170720BHEP Ipc: A61K 8/92 20060101ALI20170720BHEP Ipc: A61K 8/97 20170101AFI20170720BHEP |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1230496 Country of ref document: HK |
|
17Q | First examination report despatched |
Effective date: 20181025 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20200713 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1230496 Country of ref document: HK |